Skip to main content
Bloomberg News Interviews

Bloomberg QuickTake

Infectious Disease Expert Amesh Adalja and Epidemiologist Keri Althoff appeared weekly on Bloomberg QuickTake's 'QuickTake Charge' to share their thoughts on the latest news and findings surrounding the COVID-19 pandemic in the U.S. and globally. 

You can view previous Bloomberg QuickTake segments below. 

Amesh Adalja on Quicktake
March 23, 2022

Omicron BA.2 subvariant gains ground in U.S.

Amesh Adalja, MD, discusses the BA.2 subvariant circulating in the U.S. and the potential risks it may pose to the population. 

Amesh Adalja on Quicktake
March 7, 2022

Divided global pandemic response

Amesh Adalja, MD, discusses the roll back of various mitigation measures and vaccine mandates across the U.S., explaining these restrictions should be tied to relevant data such as hospitalizations, which are unlikely to surge again due to population immunity and key antivirals and treatments.

Amesh Adalja on Bloomberg Quicktake
February 23, 2022

Hong Kong faces worst outbreak on record for China

Amesh Adalja, MD, discusses the latest COVID outbreak in Hong Kong, emphasizing the importance of addressing vaccine hesitancy, particularly among elderly and other vulnerable populations

Keri Althoff Bloomberg QuickTake
February 18, 2022

White House warns that COVID funding is drying up

Keri Althoff, associate professor of Epidemiology, discusses the White House funding for pandemic preparedness, as well as what living with COVID will look like in the coming weeks/months. 

Amesh Adalja on Quicktake
February 16, 2022

What to expect from COVID's next six months

Amesh Adalja, MD, discusses the next six months of the COVID pandemic and what the "new normal" will look like depending on people's risk tolerance. 

Keri Althoff on Bloomberg QuickTake
February 11, 2022

CDC studies advice for easing mask rules

Keri Althoff, associate professor of Epidemiology, discusses certain areas easing mitigation strategies, such as masking, as COVID cases and hospitalizations start to decline across the U.S. 
 

Amesh Adalja on Bloomberg Quicktake
February 9, 2022

Democratic-led states revisit mask mandates

Amesh Adalja, MD, explains population immunity, discussing what mitigation strategies can be rolled back as the pandemic is seemingly moving towards an endemic state. 

Amesh Adalja on Bloomberg Quicktake
February 2, 2022

Pfizer seeks clearance for COVID shot in young kids

Amesh Adalja, MD, discusses the expected timeline for children under five to begin receiving COVID vaccines. 

Amesh Adalja on Bloomberg Quicktake
January 26, 2022

Can States or Companies Issue Vaccine Mandates?

Amesh Adalja, MD, discusses employer vaccine mandates after the Supreme Court's rejection of a vaccine-or-test federal rule. 

Keri Althoff on Bloomberg Quicktake
January 21, 2022

Nations worldwide reconsider COVID-19 restrictions

Keri Althoff discusses the latest outlook on Omicron and coronavirus restrictions as we start to see case numbers decrease globally. 

Amesh Adalja on Bloomberg Quicktake
January 20, 2022

On year into Biden's presidency

Amesh Adalja discusses the how the changing COVID-19 guidance throughout the pandemic has influenced people's perception. 

Keri Althoff Bloomberg Quicktake
January 14, 2022

Omicron deaths in South Africa peaked at 15% of delta

Keri Althoff, associate professor of Epidemiology, discusses the trend in COVID cases, hospitalizations, and surges across the country. 

Amesh Adalja on Bloomberg Quicktake
January 12, 2022

Biden team looks to ramp up testing

Amesh Adalja, MD, discusses the importance of testing throughout the pandemic and the role it will play in moving COVID to an endemic state.

Keri Althoff on Bloomberg Quicktake
January 10, 2022

US sees most COVID hospital patients since pandemic onset

Keri Althoff, associate professor of Epidemiology, discusses the trends in COVID cases throughout the U.S. and the importance of tracking this data. 

Amesh Adalja on Bloomberg Quicktake
January 5, 2022

Pandemic expectations for 2022

Amesh Adalja, MD, discusses pandemic expectations for 2022 as the Omicron variant continues to spread. 

The Bloomberg School of Public Health is supported by Michael R. Bloomberg, founder and majority owner of Bloomberg LP, the parent company of Bloomberg News. (Source: Bloomberg)